Stem cell markers CD82 [66], CD70/CD27, and Wnt receptor Fzd1 are correlated in their proliferation and chemotherapy resistance for AML cells via activation of the Wnt–β-catenin signaling pathway. The gene discussed is CD70; the disease is acute myeloid leukemia.